Search Results
Sep 22, 2025, 02:51 ET Akeso Announces First Patient Dosed in Registrational Phase II Study of TIGIT/TGF-β Bifunctional Antibody Fusion Protein AK130 Combined with Ivonescimab for Advanced Pancreatic Cancer
initiation of the AK130-202 study marks a significant milestone in Akeso's strategy approach of "IO2.0 + IO2.0" combinations. This clinical development strengthens Akeso's leadership position in the emerging global IO 2.0 cancer therapy landscape. To date, Akeso has nine self-developed bispecific antibodies
More news about: Akeso, Inc.
Sep 18, 2025, 15:41 ET SAM Medical amplía su oferta médica de emergencia con la adquisición estratégica de TyTek Medical
incluyendo la reconocida férula SAM®. La compañía también es reconocida por su torniquete para extremidades SAM® XT y el sistema de acceso intraóseo SAM® IO, entre otros productos innovadores. Con sede cerca de Portland, Oregón, SAM® Medical está a la vanguardia
More news about: SAM Medical
Sep 18, 2025, 09:00 ET Damon I/O Positioned to Be One of the First Personal Mobility Platforms to Offer End-to-End Encrypted Telematics
content:https://www.prnewswire.com/news-releases/damon-io-positioned-to-be-one-of-the-first-personal-mobility-platforms-to-offer-end-to-end-encrypted-telematics-302560258.html
More news about: DAMON Motors Inc.
Sep 18, 2025, 08:30 ET interop.io Launches io.Intelligence to Accelerate Secure Enterprise Deployment of AI Copilots
https://mma.prnewswire.com/media/2094792/interop_io_updated_Logo.jpg
More news about: interop.io
Sep 18, 2025, 00:24 ET SAM Medical élargit son offre de produits médicaux d'urgence avec l'acquisition stratégique de TyTek Medical
notamment l'attelle SAM® , largement connue. La société est également connue pour son SAM® XT Extremity Tourniquet et SAM® IO Intraosseous Access System, parmi d'autres produits innovants. Basé près de Portland, dans l'Oregon,
More news about: SAM Medical
Sep 18, 2025, 00:18 ET SAM Medical erweitert sein Angebot im Bereich Notfallmedizin durch die strategische Übernahme von TyTek Medical
darunter die weithin bekannte SAM® Schiene. Das Unternehmen ist auch bekannt für sein SAM® XT Extremity Tourniquet und SAM® IO Intraosseous Access System, neben anderen innovativen Produkten. SAM® Medical mit Sitz in der Nähe von Portland,
More news about: SAM Medical
Sep 17, 2025, 16:28 ET SAM Medical expands emergency medical offering with strategic acquisition of TyTek Medical
including the widely known SAM® Splint. The company also is well known for its SAM® XT Extremity Tourniquet and SAM® IO Intraosseous Access System, among other innovative products. Based near Portland, Oregon, SAM® Medical
More news about: SAM Medical
Sep 17, 2025, 16:06 ET SAM Medical expands emergency medical offering with strategic acquisition of TyTek Medical
including the widely known SAM® Splint. The company also is well known for its SAM® XT Extremity Tourniquet and SAM® IO Intraosseous Access System, among other innovative products. Based near Portland, Oregon, SAM® Medical
More news about: SAM Medical
Sep 17, 2025, 09:00 ET Mueon Emerges From Stealth with $15.5M Seed to Redefine Data Centers for the AI Era
Portland, Oregon, the Mueon team brings together experts in CPU, GPU, memory architecture, system Integration, Power Delivery, Thermals, and IO design, leaders who have shipped billions of units and helped shape three decades of Moore's Law. For more information, visit:
More news about: Mueon Corporation
Sep 15, 2025, 08:35 ET MSA Safety Debuts Two New Safety Solutions at National Safety Congress
handheld use or to wear. The ALTAIR io 6 Multigas Detector will join the ALTAIR io™ 4 Gas Detection Wearable on the MSA Connected Work Platform. While the ALTAIR io 4 is primarily used as a personal, continuous monitoring device, the ALTAIR io 6 is designed for sampling spaces on job
More news about: MSA Safety
Sep 15, 2025, 08:30 ET Innovative Therapeutics Pipeline Positions Industry for Strong Market Growth
cancer and rare disease treatment. The company is joining other leading innovators in the cancer and rare disease treatment space, including IO Biotech Inc. (NASDAQ: IOBT), Sarepta Therapeutics Inc. (NASDAQ: SRPT),
More news about: NetworkNewsWire
Sep 15, 2025, 07:00 ET Everon signs agreement to acquire multifamily business from ADT
and customer service champion, protecting commercial property, people, and assets. Corporate offices and our Innovation & Operations headquarters (iO) are based in the Dallas area in Irving, Texas. For more information, please visit
More news about: Everon, LLC
Sep 15, 2025, 00:11 ET Akeso Announces First Patient Dose in Global Registrational Trial of Cadonilimab (PD-1/CTLA-4) for PD-1 Treatment-Resistant Hepatocellular Carcinoma
treatment options. Currently, immune checkpoint inhibitor (IO) combination therapies have become the standard first-line treatment for various advanced malignancies. However, for patients worldwide whose disease progresses after IO combination therapy, there is a lack of effective second-line treatment
More news about: Akeso, Inc.